Arcutis Biotherapeutics I... (ARQT)
13.75
0.47 (3.54%)
At close: Jan 15, 2025, 11:59 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -0.85 | -2.54 | -4.98 | -7.4 | -19.77 | -41.03 | -158.69 |
| PS Ratio | 3.76 | 220.97 | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 2.52 | 3.89 | 3.44 | 3.71 | -12.77 | -32.93 | -158.21 |
| P/FCF Ratio | -0.9 | -2.9 | -5.83 | -8.85 | -19.25 | -56.08 | -209.26 |
| P/OCF Ratio | -0.91 | -3.16 | -5.87 | -8.88 | -19.38 | -56.08 | -209.26 |
| OCF/S Ratio | -4.14 | -69.92 | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 2.32 | 0.97 | 0.26 | 0.02 | -0.00 | n/a | -0.19 |
| Quick Ratio | 6.80 | 11.37 | 12.05 | 12.98 | 20.33 | 19.12 | 5.52 |
| Current Ratio | 7.08 | 11.57 | 12.09 | 12.96 | 20.33 | 19.12 | 5.52 |
| Asset Turnover | 0.17 | 0.01 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -8.11 | -19.27 | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -2.96 | -1.53 | -0.69 | -0.5 | 0.65 | 0.80 | 1.00 |
| Return on Assets (ROA) | -0.77 | -0.72 | -0.5 | -0.45 | -0.39 | -0.38 | -1.3 |
| Return on Capital (ROIC) | -0.82 | -0.73 | -0.55 | -0.5 | -0.42 | -0.41 | -1.31 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 91.63% | 79.54% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -439.79% | -8.72K% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -434.57% | -8.45K% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -404.49% | -8.18K% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -415.2% | -7.62K% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -381.56% | -7.99K% | n/a | n/a | n/a | n/a | n/a |